Trial Profile
A Randomized, Phase II Study of Two Dose Levels of ATN-224 in Patients With Biochemically Relapsed, Early Stage Prostate Cancer Not on Hormone Therapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiomolibdate choline (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Attenuon
- 31 May 2009 Interim results presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO-2009).
- 28 May 2009 Planned number of patients changed from 50 to 50.
- 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2008, as reported by clinicaltrials.gov.